Ligand · 8Q7
8Q7 · 9-[(1S)-2,2-difluorocyclopropane-1-carbonyl]-6-[(4-methoxyphenyl)methyl]-8,9,10,11-tetrahydropyrido[4', 3':4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one
8Q7, 9-[(1S)-2,2-difluorocyclopropane-1-carbonyl]-6-[(4-methoxyphenyl)methyl]-8,9,10,11-tetrahydropyrido[4', 3':4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one (C22 H19 F2 N5 O3 S, 471.5 g/mol), in the MolNFT structures on…
- Component
- 8Q7
- Formula
- C22 H19 F2 N5 O3 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
8Q7 in 2 structures; the first of them:
- 5UWF · Crystal structure of human PDE10A in complex with inhibitor 16d · 8Q7 C801 · binds TYR524, HIS525, LEU635, ASP674, LEU675, SER677, VAL678, ILE692 and 8 more
- 5UWF · Crystal structure of human PDE10A in complex with inhibitor 16D · 8Q7 C801 · binds TYR524, HIS525, ASP674, LEU675, SER677, VAL678, ILE692, TYR693 and 6 more
Residues it binds most
PHE 4, TYR 4, ILE 4, LEU 4, MET 4, VAL 4, GLN 4, HIS 4, SER 4, ASP 3 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.